Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Meridian | MRBK | Sep 30, 2024 | 12.64 | +0.24 |
MeridianLink | MLNK | Sep 30, 2024 | 20.57 | -2.00 |
Merit Medical Systems | MMSI | Sep 30, 2024 | 98.83 | +1.18 |
Meritage Homes | MTH | Sep 30, 2024 | 205.07 | +0.65 |
Merrill Lynch & Co. | IPB | Sep 30, 2024 | 26.74 | +0.15 |
Mersana Therapeutics | MRSN | Sep 30, 2024 | 1.89 | +2.16 |
Merus N.V | MRUS | Sep 30, 2024 | 49.96 | +4.65 |
Mesa Air Group | MESA | Sep 30, 2024 | 1.21 | +2.54 |
Mesa Laboratories | MLAB | Sep 30, 2024 | 129.86 | +1.68 |
Mesa Royalty Trust | MTR | Sep 30, 2024 | 5.67 | -1.48 |
Mesabi Royalty Trust | MSB | Sep 30, 2024 | 22.65 | -0.66 |
Mesoblast ADR | MESO | Sep 30, 2024 | 8.17 | +7.50 |
Meta Materials | MMAT | Sep 30, 2024 | 0.64 | 0.00 |
Meta Platforms A | META | Sep 30, 2024 | 572.44 | +0.90 |
Metagenomi | MGX | Sep 30, 2024 | 2.17 | -2.25 |
Metal Sky Star Acquisition | MSSA | Sep 30, 2024 | 11.45 | -0.26 |
Metalla Royalty & Streaming | MTA | Sep 30, 2024 | 3.09 | -3.13 |
Metallus | MTUS | Sep 30, 2024 | 14.83 | -0.87 |
Metals Acquisition | MTAL | Sep 30, 2024 | 13.85 | +0.65 |
Methalpa Technology Holding | MATH | Sep 30, 2024 | 1.25 | 0.00 |
Methanex | MEOH | Sep 30, 2024 | 41.34 | -0.70 |
Methode Electronics | MEI | Sep 30, 2024 | 11.96 | -0.08 |
MetLife | MET | Sep 30, 2024 | 82.48 | 0.00 |
Metlife Pref A | MET-A | Sep 30, 2024 | 24.30 | -1.54 |
Metlife Pref E | MET-E | Sep 30, 2024 | 24.74 | -0.56 |
Metlife Pref F | MET-F | Sep 30, 2024 | 22.69 | -1.56 |
MetroCity Bankshares | MCBS | Sep 30, 2024 | 30.62 | +3.13 |
Metropolitan Bank | MCB | Sep 30, 2024 | 52.58 | +2.90 |
Mettler-Toledo International | MTD | Sep 30, 2024 | 1 499.70 | +1.41 |
Mexco Energy | MXC | Sep 30, 2024 | 12.14 | -2.33 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.